| Literature DB >> 35994479 |
Carolina Cardona1,2, Funmilola M OlaOlorun3, Elizabeth Omulabi4, Peter Gichangi5,6, Mary Thiogo5, Amy Tsui1, Philip Anglewicz1.
Abstract
Although researchers and practitioners have suggested that the quality of family planning services impacts contraceptive discontinuation, establishing a causal relationship has been challenging, primarily due to data limitations and a lack of agreement on how to measure quality. This longitudinal study estimated the relationship of the dissatisfaction with family planning services on contraceptive discontinuation for a sample of 797 female clients who sought family planning services at urban facilities across Kenya, Nigeria, and Burkina Faso. Clients who sought family planning services were first interviewed in person at private and public health facilities and received a follow-up phone interview four to six months later. In our sample, 18.2% of clients who were using a modern contraceptive at baseline stopped using it by follow-up. At baseline, nearly 14% of clients reported experiencing a problem with service convenience, nearly 12% with the availability of medicines and contraceptives, and nearly 6% with facility cleanliness and/or staff treatment. We hypothesized that client dissatisfaction with the family planning services received informed their decision to discontinue contraception and estimated univariate and bivariate probit regression models, controlling for individual and health facility characteristics. We found that client's perceptions of staff treatment and facility cleanliness informed their expectations about service and contraceptive standards, affecting subsequent contraceptive discontinuation. The difference in the probability of discontinuing contraception was 8.2 percentage-points between dissatisfied and satisfied clients. Examining client dissatisfaction with family planning services can inform the family planning community on needed improvements to increase contraceptive adherence for women in need, which can prevent unplanned pregnancies and unwanted births in the long run.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35994479 PMCID: PMC9394817 DOI: 10.1371/journal.pone.0271911
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Principal component analysis (PCA), component loadings, orthogonal varimax rotation of loading matrix after PCA.
| Orthogonal Varimax Rotation | |||||
|---|---|---|---|---|---|
| Item | Comp. 1 = | Comp. 2 = | Comp. 3 = | Comp. 4 = | Unexplained |
| Availability | Privacy | Convenience | Clean/Staff treatment | ||
| Range of services available |
| 0.102 | -0.003 | -0.110 | 0.429 |
| Availability of medicines |
| 0.007 | -0.026 | -0.065 | 0.408 |
| Availability of contraceptives |
| -0.065 | 0.093 | 0.023 | 0.518 |
| Visual privacy during examination | 0.003 |
| -0.013 | 0.113 | 0.193 |
| Auditory privacy during examination | 0.015 |
| 0.001 | -0.060 | 0.215 |
| Hours of Service | 0.018 | 0.030 |
| -0.106 | 0.493 |
| Days of service | 0.178 | 0.066 |
| 0.060 | 0.539 |
| Time waited to see a provider | -0.046 | -0.136 |
| 0.235 | 0.559 |
| Cleanliness of the facility | -0.214 | 0.113 | 0.134 |
| 0.407 |
| Staff treatment | 0.163 | -0.063 | -0.222 |
| 0.539 |
| Amount of explanation received | 0.234 | -0.050 | 0.148 | 0.307 | 0.676 |
| Cost of services or treatment | 0.198 | -0.051 | -0.318 | 0.319 | 0.704 |
Note: Bold values indicate the item is loading on the component. Obs. = 775.
Sample characteristics of family planning clients stratified by contraceptive discontinuation status.
| Variables | Total | Contraceptive discontinuation | |||
|---|---|---|---|---|---|
| Discontinuer | Continuer | ||||
| Obs. | % | % | % | ||
| Contraceptive discontinuation | |||||
| Discontinuer | 145 | 18.2 | |||
| Continuer | 652 | 81.8 | |||
| Reports problems with | |||||
| Availability | 797 | 11.9 | 13.1 | 11.7 | 0.24 (0.627) |
| Privacy | 797 | 3.5 | 2.8 | 3.7 | 0.30 (0.585) |
| Convenience | 797 | 13.6 | 13.1 | 13.7 | 0.03 (0.862) |
| Clean/Staff treatment | 797 | 5.8 | 9.7 | 4.9 |
|
| Managing authority | |||||
| Private | 123 | 15.9 | 19.9 | 15.0 | 2.01 (0.157) |
| Public | 650 | 84.1 | 80.1 | 85.0 | |
| Contraceptive stocks | |||||
| In-stock | 672 | 86.9 | 85.8 | 87.2 | 0.19 (0.663) |
| Not offered/Out-of-stock | 101 | 13.1 | 14.2 | 12.8 | |
| Fee for FP methods | |||||
| No | 449 | 58.1 | 48.9 | 60.1 |
|
| Yes | 324 | 41.9 | 51.1 | 39.9 | |
| Provider discussed FP | |||||
| No | 175 | 22.0 | 29.0 | 20.4 |
|
| Yes | 622 | 78.0 | 71.0 | 79.6 | |
| Used the baseline method before the visit | |||||
| No | 221 | 27.7 | 29.0 | 27.5 | 0.14 (0.713) |
| Yes | 576 | 72.3 | 71.0 | 72.5 | |
| Baseline method | |||||
| Long-acting reversible contraception | 248 | 31.1 | 42.1 | 28.7 |
|
| Short-acting reversible contraception | 549 | 68.9 | 57.9 | 71.3 | |
| Heard FP in radio or TV (last 3 months) | |||||
| No | 233 | 29.3 | 31.0 | 28.9 | 0.26 (0.614) |
| Yes | 562 | 70.7 | 69.0 | 71.1 | |
| CHW talked about FP recently | |||||
| No | 692 | 87.0 | 86.2 | 87.2 | 0.11 (0.740) |
| Yes | 103 | 13.0 | 13.8 | 12.8 | |
| Marital status | |||||
| In union | 720 | 90.3 | 88.3 | 90.8 | 0.86 (0.353) |
| Not in union | 77 | 9.7 | 11.7 | 9.2 | |
| Age | |||||
| 18–24 | 203 | 25.5 | 28.3 | 24.8 |
|
| 25–34 | 399 | 50.1 | 56.6 | 48.6 | |
| 35–49 | 195 | 24.5 | 15.2 | 26.5 | |
| Parity | |||||
| None-1 | 184 | 23.1 | 35.2 | 20.4 |
|
| 2–3 | 387 | 48.6 | 42.1 | 50.0 | |
| 4+ | 226 | 28.4 | 22.8 | 29.6 | |
| Education | |||||
| None/primary | 266 | 33.4 | 40.0 | 31.9 | 3.91 (0.142) |
| Post-primary/Secondary | 370 | 46.4 | 40.0 | 47.9 | |
| College/University | 161 | 20.2 | 20.0 | 20.2 | |
| Wealth | |||||
| Poorest | 298 | 37.6 | 43.4 | 36.3 | 2.81 (0.245) |
| Middle | 395 | 49.8 | 46.2 | 50.6 | |
| Richest | 100 | 12.6 | 10.3 | 13.1 | |
| Discussed FP w/ partner (last 6 months) | |||||
| No | 268 | 33.7 | 42.4 | 31.7 |
|
| Yes | 528 | 66.3 | 57.6 | 68.3 |
|
Notes: Bold values indicate significant differences between discontinuers and continuers. Table A-8 in S1 Appendix provides a detailed description of these variables and whether they were retrieved from the CEI or SDP questionnaire.
*** p<0.01
** p<0.05
* p<0.1.
Results from probit regression models of client dissatisfaction with family planning services on contraceptive discontinuation.
| Outcome: Contraceptive Discontinuation | |||||
|---|---|---|---|---|---|
| Reports problem w/ availability ( | Reports problem w/ privacy | Reports problem w/ convenience | Reports problem w/ clean/staff treatment | ||
| Model 1 | Coeff. | 0.137 [-0.228–0.502] | -0.372 [-0.982–0.239] | 0.003 [-0.342–0.348] |
|
| Avg. Marg. Effects | 0.033 [-0.055–0.121] | -0.090 [-0.237–0.057] | 0.001 [-0.083–0.084] |
| |
| Model 2 | Coeff. | 0.134 [-0.212–0.479] | |||
| Avg. Marg. Effects | 0.032 [-0.051–0.116] | ||||
| Model 3 | Coeff. | -0.266 [-0.855–0.323] | |||
| Avg. Marg. Effects | -0.065 [-0.207–0.078] | ||||
| Model 4 | Coeff. | 0.031 [-0.297–0.359] | |||
| Avg. Marg. Effects | 0.007 [-0.072–0.087] | ||||
| Model 5 | Coeff. | 0.320 [-0.071–0.711] | |||
| Avg. Marg. Effects | 0.078 [-0.017–0.172] | ||||
Notes: Reporting probit coefficients (Coeff.) with 95% CIs computed with robust standard errors in brackets. Reporting average marginal effects (Avg. Marg. Effects) with CIs computed with the delta-method in brackets. All models control for country fixed effects. Control variables included were: managing authority, contraceptive stocks, fee for family planning methods, provider discussed family planning, used the baseline method before the visit, baseline method, heard about family planning in the radio or TV, talked recently with a CHW about family planning, marital status, age, parity, education, household wealth, and discussed about family planning with partner. Full model is presented in Table A-4 in S1 Appendix.
*** p<0.01
** p<0.05
* p<0.1.
Regression results from the seemingly unrelated bivariate probit models.
| Model 2 | Model 3 | Model 4 | Model 5 | |||||
|---|---|---|---|---|---|---|---|---|
| Variables | Disconti-nuer | Problem w/ availability | Disconti-nuer | Problem w/ privacy | Disconti-nuer | Problem w/ convenience | Disconti-nuer | Problem w/ clean/staff treatment |
| Inverse hyperbolic tangent of | 0.111 | -0.164 | 0.031 | 0.152 | ||||
| [-0.070–0.292] | [-0.406–0.078] | [-0.146–0.208] | [-0.044–0.348] | |||||
|
| ||||||||
| Public | -0.151 |
| -0.158 | 0.082 | -0.155 |
| -0.157 | 0.024 |
| [-0.493–0.190] | [0.122–1.114] | [-0.500–0.185] | [-0.547–0.711] | [-0.497–0.186] | [0.276–1.362] | [-0.501–0.187] | [-0.468–0.517] | |
|
| ||||||||
| Not offered/Out-of-stock | 0.130 |
| 0.130 | -0.056 | 0.128 | -0.231 | 0.126 | -0.254 |
| [-0.197–0.457] | [0.321–1.009] | [-0.195–0.456] | [-0.565–0.452] | [-0.198–0.455] | [-0.642–0.181] | [-0.201–0.453] | [-0.803–0.296] | |
|
| ||||||||
| Yes | 0.149 | -0.066 | 0.145 | 0.245 | 0.147 | -0.079 | 0.145 | -0.066 |
| [-0.150–0.448] | [-0.445–0.313] | [-0.152–0.443] | [-0.219–0.709] | [-0.151–0.446] | [-0.413–0.255] | [-0.154–0.443] | [-0.451–0.318] | |
|
| ||||||||
| Yes |
| 0.158 |
| 0.078 |
| -0.080 |
| -0.153 |
| [-0.558 - -0.037] | [-0.149–0.466] | [-0.557 - -0.037] | [-0.342–0.497] | [-0.561 - -0.041] | [-0.373–0.212] | [-0.560 - -0.039] | [-0.505–0.200] | |
|
| ||||||||
| Yes | 0.112 | 0.029 | 0.112 | 0.048 | 0.111 |
| 0.110 | 0.113 |
| [-0.155–0.379] | [-0.263–0.320] | [-0.155–0.379] | [-0.362–0.458] | [-0.155–0.378] | [-0.608 - -0.067] | [-0.157–0.376] | [-0.255–0.480] | |
|
| ||||||||
| Short-acting reversible contraception |
| -0.061 |
|
|
| -0.112 |
| -0.171 |
| [-0.653 - -0.166] | [-0.343–0.220] | [-0.655 - -0.167] | [-0.958 - -0.180] | [-0.653 - -0.165] | [-0.379–0.155] | [-0.650 - -0.162] | [-0.495–0.153] | |
|
| ||||||||
| Yes | -0.030 | -0.027 | -0.029 | 0.054 | -0.030 | -0.039 | -0.034 |
|
| [-0.274–0.213] | [-0.311–0.256] | [-0.272–0.214] | [-0.379–0.488] | [-0.273–0.213] | [-0.319–0.241] | [-0.276–0.209] | [-0.575–0.050] | |
|
| ||||||||
| Yes | 0.039 | 0.100 | 0.034 | 0.162 | 0.038 |
| 0.038 | 0.050 |
| [-0.288–0.365] | [-0.268–0.467] | [-0.293–0.361] | [-0.332–0.656] | [-0.289–0.364] | [-0.918 - -0.115] | [-0.287–0.364] | [-0.391–0.492] | |
|
| ||||||||
| Not in union | 0.002 | -0.002 | 0.005 | 0.309 | 0.005 | -0.008 | 0.005 | 0.152 |
| [-0.387–0.392] | [-0.407–0.403] | [-0.383–0.393] | [-0.195–0.814] | [-0.384–0.394] | [-0.405–0.389] | [-0.386–0.395] | [-0.355–0.658] | |
|
| ||||||||
| 25–34 |
|
|
|
|
| 0.254 |
| 0.166 |
| [-0.009–0.576] | [-0.005–0.645] | [-0.008–0.573] | [0.188–1.005] | [-0.008–0.575] | [-0.064–0.572] | [-0.008–0.577] | [-0.211–0.542] | |
| 35–49 | -0.101 |
| -0.101 |
| -0.101 |
| -0.098 | 0.375 |
| [-0.498–0.297] | [-0.056–0.751] | [-0.495–0.294] | [-0.060–1.058] | [-0.497–0.295] | [0.196–0.992] | [-0.494–0.299] | [-0.074–0.824] | |
|
| ||||||||
| 2–3 |
| 0.089 |
| -0.059 |
| -0.088 |
| 0.013 |
| [-0.834 - -0.236] | [-0.255–0.433] | [-0.826 - -0.231] | [-0.443–0.326] | [-0.831 - -0.234] | [-0.413–0.238] | [-0.833 - -0.234] | [-0.358–0.383] | |
| 4+ |
| -0.158 |
|
|
| -0.147 |
|
|
| [-0.974 - -0.186] | [-0.584–0.268] | [-0.973 - -0.188] | [-1.520 - -0.303] | [-0.974 - -0.188] | [-0.566–0.272] | [-0.976 - -0.186] | [-0.958 - -0.040] | |
|
| ||||||||
| Post-Primary/Secondary |
|
|
| -0.003 |
| 0.112 |
| -0.255 |
| [-0.596 - -0.089] | [-0.014–0.568] | [-0.605 - -0.098] | [-0.444–0.438] | [-0.599 - -0.091] | [-0.152–0.376] | [-0.600 - -0.091] | [-0.593–0.082] | |
| College/University |
| -0.064 |
| -0.014 |
| -0.025 |
| 0.066 |
| [-0.723 - -0.043] | [-0.487–0.359] | [-0.727 - -0.050] | [-0.604–0.576] | [-0.722 - -0.043] | [-0.420–0.370] | [-0.720 - -0.041] | [-0.360–0.493] | |
|
| ||||||||
| Middle (4–5) | -0.127 | 0.038 | -0.121 | 0.018 | -0.124 | -0.194 | -0.123 | -0.055 |
| [-0.372–0.119] | [-0.252–0.329] | [-0.367–0.125] | [-0.387–0.423] | [-0.370–0.122] | [-0.465–0.076] | [-0.369–0.123] | [-0.385–0.275] | |
| Richest (6–10) | -0.211 | 0.007 | -0.213 | -0.164 | -0.215 | -0.199 | -0.217 | -0.131 |
| [-0.595–0.173] | [-0.438–0.451] | [-0.597–0.172] | [-0.821–0.493] | [-0.600–0.170] | [-0.614–0.216] | [-0.603–0.168] | [-0.633–0.372] | |
|
| ||||||||
| Yes |
|
|
| -0.191 |
| -0.049 |
| -0.200 |
| [-0.503–0.003] | [-0.557 - -0.042] | [-0.500–0.006] | [-0.612–0.229] | [-0.500–0.006] | [-0.311–0.213] | [-0.497–0.008] | [-0.525–0.125] | |
| Constant | 0.175 |
| 0.174 |
| 0.176 |
| 0.175 |
|
| [-0.392–0.743] | [-2.550 - -1.050] | [-0.394–0.741] | [-2.589 - -0.685] | [-0.392–0.744] | [-1.857 - -0.316] | [-0.394–0.745] | [-2.060 - -0.435] | |
| Observations | 765 | 765 | 765 | 765 | 765 | 765 | 765 | 765 |
Notes: Reporting probit coefficients with 95% Cis computed with robust standard errors in brackets. All models control for country fixed effects. is the inverse hyperbolic tangent of the correlation between the error terms shown in Eq 2.
*** p<0.01
** p<0.05
* p<0.1.